Clinical evaluation of lipids, lipoproteins and red blood cells sodium and potassium in patients with different grades of hypertension

Clinical Biochemistry

Volumn 43, Issue 12, 2010, Pages 942-947

  Aribi, Mourad ^a   Merzouk, Hafida ^a   Haddouche, Mustapha ^a   Benyoucef, Mohammed ^b   Taleb, Abdesselam ^a,b   Kendouci Tani, Mohammed ^a,b   Merzouk, Sid A ^a   Meziane, Abderrahim ^b  

^a UNIVERSITY OF TLEMCEN   (Algeria)

^b Ctr Hosp Universitaire de Tlemcen   (Algeria)

Author keywords

Grade of hypertension; Lipids; Lipoproteins; Sodium and potassium fluxes

Indexed keywords

LIPID; LIPOPROTEIN; POTASSIUM; SODIUM;

ADULT; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD SAMPLING; CELL LEVEL; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; ERYTHROCYTE; FEMALE; HUMAN; HUMAN CELL; HYPERTENSION; MALE; POTASSIUM TRANSPORT; PRIORITY JOURNAL; SODIUM TRANSPORT; BLOOD; METABOLISM; MIDDLE AGED;

ADULT; ERYTHROCYTES; FEMALE; HUMANS; HYPERTENSION; LIPIDS; LIPOPROTEINS; MALE; MIDDLE AGED; POTASSIUM; SODIUM;

EID: 77954310482     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2010.05.012     Document Type: Article

References (58)

1. Cohen Y., Jacquot C. Pharmacologie 2008, Elsevier Masson SAS, Issy-les-Moulineaux. 6th ed.
2. Flesch M., Sachinidis A., Ko Y.D., Kraft K., Vetter H. Plasma lipids and lipoproteins and essential hypertension. Clin Investig 1994, 72:944-950.
3. Kullo I.J., Andrade M., Boerwinkle E., McConnell J.P., Kardia S., Turner S.T. Pleiotropic genetic effects contribute to the correlation between HDL cholesterol, triglycerides, and LDL particle size in hypertensive sibships. Am J Hypertens 2005, 18:99-103.
4. Ukoh V.A., Oforofuo I.A. Plasma lipid profiles in Nigerians with normal blood pressure, hypertension and other acquired cardiac conditions. East Afr Med J 2007, 84:264-270.
5. Zicha J., Kunes J., Devynck M.A. Abnormalities of membrane function and lipid metabolism in hypertension. Am J Hypertens 1999, 12:315-331.
6. Whitworth J.A. 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. J Hypertens 2003, 21:1983-1992. World Health Organization, International Society of Hypertension Writing Group.
7. Wieland H., Seidel D. A simple specific method for precipitation of low density lipoproteins. J Lipid Res 1983, 24:904-909.
8. Burstein M., Scholnick H.R., Morfin R. Rapid method for isolation of lipoproteins from human serum by precipitation with polyanions. J Lipid Res 1970, 11:583-595.
9. Warnick G.R., Benderson J., Albers J.J. Dextran sulfate-Mg2+ precipitation procedure for quantitation of high-density-lipoprotein cholesterol. Clin Chem 1982, 28:1379-1388.
10. Gidez L.I., Miller G.J., Burstein M., Slagle S., Eder H.A. Separation and quantitation of subclasses of human plasma high density lipoproteins by a simple precipitation procedure. J Lipid Res 1982, 23:1206-1223.
11. Delgado M.C., Delgado-Almeida A. Red blood cell K+could be a marker of K+changes in other cells involved in blood pressure regulation. J Hum Hypertens 2003, 17:313-318.
12. 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 2003, 21:1011-1053. European Society of Hypertension-European Society of Cardiology Guidelines Committee.
13. Messerli F. Obesity, hypertension, and cardiovascular disease. JAMA 1987, 257:1598-1599.
14. Phillips A., Shaper A.G. Relative weight and major ischemic heart disease events in hypertensive men. Lancet 1989, 1:1005-1008.
15. Martins D., Tareen N., Pan D., Norris K. The relationship between body mass index and pulse pressure in older adults with isolated systolic hypertension. Am J Hypertens 2002, 15:538-543.
16. Barrett-Connor E.L. Obesity, atherosclerosis, and coronary disease. Ann Intern Med 1985, 103:1010-1019.
17. Kissebah A.H., Freedman D.S., Peiris A.N. Health risk of obesity. Med Clin North Am. 1989, 73:111-138.
18. Goldbourt U., Holtzman E., Cohen-Mandelzweig L., Neufeld H.N. Enhanced risk of coronary heart disease mortality in lean hypertensive men. Hypertension 1987, 10:22-28.
19. Appel G.B., Radhakrishnan J., Avram M.M., DeFronzo R.A., Escobar-Jimenez F., Campos M.M., et al. RENAAL Study, Analysis of metabolic parameters as predictors of risk in the renal study. Diab Care 2003, 26:1402-1407.
20. Gurav R.B., Kartikeyan S., Jadhav B.S. Biochemical profile of hypertensive individuals in an urban community. Indian J Med Sci 2001, 55:663-668.
21. Ouppatham S., Bancha S., Choovichian P. The relationship of hyperuricemia and blood pressure in the Thai army population. J Postgrad Med 2008, 54:259-262.
22. Ward H.J. Uric acid as an independent risk factor in the treatment of hypertension. Lancet 1998, 352:670-671.
23. Freedman D.S., Williamson D.F., Gunter E.W., Byers T. Relation of serum uric acid to mortality and ischemic heart disease, The NHANES I Epidemiologic Follow-up Study. Am J Epidemiol 1995, 141:637-644.
24. Longo-Mbenza B., Luila E.L., Mbette P., Vita E.K. Is hyperuricemia a risk factor of stroke and coronary heart disease among Africans?. Int J Cardiol 1999, 30:17-22.
25. Perlstein T.S., Gumieniak O., Williams G.H., Sparrow D., Vokonas P.S., Gaziano M., et al. Uric acid and the development of hypertension: the normative aging study. Hypertension 2006, 48:1031-1036.
26. Oghagbon E.K., Okesina A.B. Pattern of some risk factors for cardiovascular disease in untreated Nigerian hypertensive patients. West Afr J Med 2006, 25:190-194.
27. Akuyam S.A., Aghogho U.B., Aliyu I.S., Bakari A.G. Serum total cholesterol in hypertensive Northern Nigerians. Int J Med Med Sci 2009, 3:73-78.
28. Castelli W.P., Anderson K. A population at risk: prevalence of high cholesterol levels in hypertensive patients in the Framingham Study. Am J Med 1986, 80:23-32.
29. Marotta T., Ferrara L.A., Di Marino L., Mancini M., Annuzzi G., Russo O., et al. Factors affecting lipoprotein lipase in hypertensive patients. Metabolism 1995, 44:712-718.
30. Landray M.J., Edmunds E., Li-Saw-Hee F.L., Hughes B.A., Beevers D.G., Kendall M.J., et al. Abnormal low density lipoprotein subfraction profile in patients with untreated hypertension. Q J Med 2002, 95:165-171.
31. Bagdade J.D., Liu X., Buchanan W.F., Hafner J., Rosenson R. Accelerated cholesteryl ester transfer in patients with essential hypertension and the effect of ramipril treatment. Atherosclerosis 1998, 140:167-172.
32. Patsch J.R., Prasad S., Grotto Jr A.M., Patsch W. High density lipoprotein2. Relationship of the plasma levels of this lipoprotein species to its composition, to the magnitude of postprandial lipemia, and to the activities of lipoprotein lipase and hepatic lipase. J Clin Invest 1987, 80:341-347.
33. Huuskonen J., Olkkonen V.M., Jauhiainen M., Ehnholm C. The impact of phospholipid transfer protein (PLTP) on HDL metabolism. Atherosclerosis 2001, 155:269-281.
34. Strazzullo P., Nunziata V., Cirillo M., Giannattasio R., Ferrara L.A., Mattioli P.L., et al. Abnormalities of calcium metabolism in essential hypertension. Clin Sci 1983, 65:137-141.
35. Resnick L.M., Muller F.B., Laragh J.H. Calcium-regulating hormones in essential hypertension: relation to plasma renin activity and sodium metabolism. Ann Intern Med 1986, 105:649-654.
36. Frohlich E.D. Hemodynamic factors in the pathogenesis and maintenance of hypertension. Fed Proc 1982, 41:2400-2408.
37. He F.J., MacGregor G.A. Beneficial effects of potassium. BMJ 2001, 323:497-501.
38. Hall J.E. The kidney, hypertension, and obesity. Hypertension 2003, 41:625-633.
39. Hall J.E., da Silva A.A., do Carmo J.M., Dubinion J., Hamza S., Munusamy S., Smith G., Stec D.E. Obesity-induced Hypertension: Role of Sympathetic Nervous System, Leptin and Melanocortins. J Biol Chem 2010, 4:17271-17276.
40. Garrison R.J., Kannel W.B., Stokes J., Castelli W.P. Incidence and precursors of hypertension in young adults: the Framingham Offspring Study. Prev Med 1987, 16:235-251.
41. Quereda C., Orte L., Sabater J., Navarro-Antolin J., Villafruela J.J., Ortuño J. Urinary calcium excretion in treated and untreated essential hypertension. J Am Soc Nephrol 1996, 7:1058-1065.
42. Kola L.D., Sumaili E.K., Krzesinski J.M. How to treat hypertension in blacks: review of the evidence. Acta Clin Belg 2009, 64:466-476.
43. Watkins W.S., Hunt S.C., Williams G.H., Tolpinrud W., Jeunemaitre X., Lalouel J.M., et al. Genotype-phenotype analysis of angiotensinogen polymorphisms and essential hypertension: the importance of haplotypes. J Hypertens 2010, 28:65-75.
44. Büssemaker E., Hillebrand U., Hausberg M., Pavenstädt H., Oberleithner H. Pathogenesis of hypertension: interactions among sodium, potassium, and aldosterone. Am J Kidney Dis 2010, 55:1111-1120.
45. Krishna G.G., Kapoor S.C. Potassium depletion exacerbates essential hypertension. Ann Intern Med 1991, 115:77-83.
46. Krishna G.G., Miller E., Kapoor S. Increased blood pressure during potassium depletion in normotensive men. N Engl J Med 1989, 320:1177-1182.
47. Krishna G.G., Chusid P., Hoeldtke R.D. Mild potassium depletion provokes renal sodium retention. J Lab Clin Med 1987, 109:724-730.
48. Adrogué H.J., Madias N.E. Sodium and potassium in the pathogenesis of hypertension. N Engl J Med 2007, 356:1966-1978.
49. de Wardener H. Natraemia, natriuresis, inhibitors of sodium transport and high blood pressure. Néphrol Thér 2007, 3:433-436.
50. Kaplan N.M. Primary hypertension: pathogenesis. Kaplan's clinical hypertension 2006, 50-121. Lippincott Williams & Wilkins, Philadelphia. 9th ed. N.M. Kaplan (Ed.).
51. Vasan R.S., Evans J.C., Larson M.G., Wilson P.W., Meigs J.B., Rifai N., Benjamin E.J., Levy D. Serum aldosterone and the incidence of hypertension in nonhypertensive persons. N Engl J Med 2004, 351:33-41.
52. Feig P.U., Mitchell P.P., Boylan J.W. Erythrocyte membrane transport in hypertensive humans and rats. Effect of sodium depletion and excess. Hypertension 1985, 7:423-429.
53. Lijnen P., Petrov V. Cholesterol modulation of transmembrane cation transport systems in human erythrocytes. Biochem Mol Med 1995, 56:52-62.
54. Zicha J., Bin Talib H.K., Duhm J. Na+and K+transport alterations in hypertension. Physiol Res 1991, 40:555-576.
55. Ishizaki M., Teraoka K., Tsuritani I., Honda R., Ishida M., Yamada Y. Erythrocyte Na+/K+-ATPase and membrane and serum lipid profiles: as related to alcohol, body mass index and blood pressure. Clin Exp Hypertens 1994, 16:741-759.
56. Johnson W.J., Bamberger M.J., Latta R.A., Rapp P.E., Phillips M.C., Rothblat G.H. The bidirectional flux of cholesterol between cells and lipoproteins, Effects of phospholipid depletion of high density lipoprotein. J Biol Chem 1986, 261:5766-5776.
57. Vokurková M., Dobesová Z., Pechánová O., Kunes J., Zicha J. Erythrocyte ion transport and membrane lipid composition in young and adult rats with NO-deficient hypertension. Life Sci 2003, 73:1637-1644.
58. Menegaux F., Trésallet C., Jublanc C., Girerd X., Chigot J.P. Unusual arterial hypertension from the adrenal gland. Ann Chir 2005, 130:426-429.